ADmit Therapeutics
Barcelona
About ADmit Therapeutics
ADmit Therapeutics is a biotechnology company that specializes in the development of early Alzheimer's disease diagnosis tests. The company's test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA by next-generation sequencing, enabling medical practitioners with an easy way to detect early-stage Alzheimer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.9M
- Last round: Series Unknown (Jul 2023)
- Website: admit-therapeutics.comen
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/admit-therapeutics-9069 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.